- Home
- YMM vs ICLR Comparison
YMM vs ICLR Comparison
Compare YMM & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- ICLR
- Stock Information
- Founded
- YMM 2011
- ICLR 1990
- Country
- YMM China
- ICLR Ireland
- Employees
- YMM N/A
- ICLR N/A
- Industry
- YMM Computer Software: Prepackaged Software
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- YMM Technology
- ICLR Health Care
- Exchange
- YMM Nasdaq
- ICLR Nasdaq
- Market Cap
- YMM 11.6B
- ICLR 11.4B
- IPO Year
- YMM 2021
- ICLR 1998
- Fundamental
- Price
- YMM $11.63
- ICLR $130.28
- Analyst Decision
- YMM Buy
- ICLR Buy
- Analyst Count
- YMM 3
- ICLR 12
- Target Price
- YMM $13.00
- ICLR $204.18
- AVG Volume (30 Days)
- YMM 7.6M
- ICLR 1.6M
- Earning Date
- YMM 05-21-2025
- ICLR 07-23-2025
- Dividend Yield
- YMM 0.83%
- ICLR N/A
- EPS Growth
- YMM 55.79
- ICLR 11.53
- EPS
- YMM 0.49
- ICLR 9.19
- Revenue
- YMM $1,608,190,451.00
- ICLR $8,192,621,999.00
- Revenue This Year
- YMM N/A
- ICLR N/A
- Revenue Next Year
- YMM $14.32
- ICLR $2.34
- P/E Ratio
- YMM $23.85
- ICLR $14.18
- Revenue Growth
- YMM 29.63
- ICLR N/A
- 52 Week Low
- YMM $6.66
- ICLR $125.10
- 52 Week High
- YMM $13.85
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- YMM 47.82
- ICLR 39.23
- Support Level
- YMM $10.93
- ICLR $125.10
- Resistance Level
- YMM $12.50
- ICLR $132.96
- Average True Range (ATR)
- YMM 0.44
- ICLR 4.34
- MACD
- YMM -0.04
- ICLR 0.79
- Stochastic Oscillator
- YMM 34.56
- ICLR 29.63
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.